Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia after Mandibular Third Molar Extraction
2015-005426-19Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of naloxone in acute postoperative pain and hyperalgesia (2 arms), sponsored by Rigshospitalet. Primary endpoint: Pain intensity after naloxone vs placebo. Started Dec 2015; status: completed.
02
Drugs
naloxone
03
Conditions
acute postoperative painhyperalgesia
Beyond the preview
Go deeper on 2015-005426-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005426-19.